指南与共识甲状腺疾病

先天性甲状腺功能减退症:2020-2021共识指南更新

Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.
指南 / 共识 · Thyroid · 2021-01-01

该共识由ENDO-ERN发起、欧洲儿科内分泌学会和欧洲内分泌学会认可,22名参与者参与,旨在更新先天性甲状腺功能减退症(CH)的诊治指南。通过系统文献检索,采用GRADE系统对推荐强度和证据质量进行分级,涵盖新生儿筛查、诊断、治疗及随访等方面。专家小组推荐确诊后立即开始正确剂量的左甲状腺素治疗,并定期随访监测甲状腺激素水平,同时关注神经发育和感觉功能。

要点

  • 确诊CH后应立即开始正确剂量的左甲状腺素治疗。
  • 定期随访包括实验室检测以维持甲状腺激素在目标范围。
  • 需及时评估继续治疗的必要性并关注神经发育。

核心结论

  • 该共识指南更新应进一步优化所有形式CH儿童的检测、诊断、治疗和随访。
  • 应有助于说服卫生当局认识到新生儿筛查CH的益处。
  • 需要进一步流行病学和实验研究来理解该病发病率增加的原因。

研究设计与样本

  • 由ENDO-ERN发起,欧洲儿科内分泌学会和欧洲内分泌学会认可,22名参与者参与。
  • 进行了系统文献检索以识别关于新生儿筛查、诊断和治疗原发性和中枢性CH的关键文章。
  • 采用GRADE系统对推荐强度和证据质量进行分级,证据不足时基于专家意见。

主要发现

  • 推荐包括CH的各种新生儿筛查方法以及原发性和中枢性CH的病因(包括遗传)、诊断、治疗和预后。
  • 专家小组推荐确诊CH后立即开始正确剂量的左甲状腺素治疗。
  • 推荐频繁随访包括实验室检测以保持甲状腺激素水平在目标范围。
  • 推荐及时评估继续治疗的必要性,关注神经发育和感觉功能,必要时咨询其他健康专业人员。
  • 推荐对儿童和家庭进行关于CH的教育。

关键数值与推荐

  • 确诊CH后立即开始正确剂量的左甲状腺素治疗。
  • 频繁随访包括实验室检测以保持甲状腺激素水平在目标范围。
  • 及时评估继续治疗的必要性。
  • 关注神经发育和感觉功能,必要时咨询其他健康专业人员。
  • 所有CH个体均有权获得从儿科到成人医学的规划良好的过渡护理。

临床怎么用

  • 确诊CH后立即开始正确剂量的左甲状腺素治疗。
  • 定期随访监测甲状腺激素水平,保持在目标范围。
  • 评估继续治疗的必要性,关注神经发育和感觉功能。
  • 对儿童和家庭进行CH教育。
  • 规划从儿科到成人医疗的过渡护理。

局限性

  • 在证据不足的情况下,结论基于专家意见。
  • 需要进一步的流行病学和实验研究来理解该病发病率增加的原因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: An ENDO-European Reference Network (ERN) initiative was launched that was endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology with 22 participants from the ENDO-ERN and the two societies. The aim was to update the practice guidelines for the diagnosis and management of congenital hypothyroidism (CH). A systematic literature search was conducted to identify key articles on neonatal screening, diagnosis, and management of primary and central CH. The evidence-based guidelines were graded with the Grading of Recommendations, Assessment, Development and Evaluation system, describing both the strength of recommendations and the quality of evidence. In the absence of sufficient evidence, conclusions were based on expert opinion. Summary: The recommendations include the various neonatal screening approaches for CH as well as the etiology (also genetics), diagnostics, treatment, and prognosis of both primary and central CH. When CH is diagnosed, the expert panel recommends the immediate start of correctly dosed levothyroxine treatment and frequent follow-up including laboratory testing to keep thyroid hormone levels in their target ranges, timely assessment of the need to continue treatment, attention for neurodevelopment and neurosensory functions, and, if necessary, consulting other health professionals, and education of the child and family about CH. Harmonization of diagnostics, treatment, and follow-up will optimize patient outcomes. Lastly, all individuals with CH are entitled to a well-planned transition of care from pediatrics to adult medicine. Conclusions: This consensus guidelines update should be used to further optimize detection, diagnosis, treatment, and follow-up of children with all forms of CH in the light of the most recent evidence. It should be helpful in convincing health authorities of the benefits of neonatal screening for CH. Further epidemiological and experimental studies are needed to understand the increased incidence of this condition.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. van Trotsenburg P, Stoupa A, Léger J, et al. Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology. Thyroid. 2021. PMID: 33272083. doi:10.1089/thy.2020.0333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。